Vertex Pharmaceuticals unveiled impressive long-term results for its CRISPR/Cas9 gene therapy, PrCASGEVY, at the EHA Congress ...

Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...

The Executive Director of the Ghana Foundation for Sickle Gene Action, Victoria Awo Twumasi, has called on President John Dramani Mahama to include full coverage of sickle cell disease treatment under ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Sickle cell disease is inherited when a child receives a copy of the sickle cell gene from both parents. It causes red blood cells to change from their normal round shape into sickle or crescent ...

In a sharply divided political climate, San Rocco Therapeutics (SRT) has done what few thought possible—earned support from both the highest levels of Washington and from those who distrust it.

A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...

Oregon will initially focus on providing lower-cost therapies for people living with sickle cell disease, a genetic blood ...

Considering a change to your treatment regimen? Columnist Mary Shaniqua shares tips to help patients and providers make an ...

This article discusses how racial categories, rooted in social history, are used in records and society. It argues race isn’t ...